. Author manuscript; available in PMC: 2010 Oct 1.

Published in final edited form as: J Mol Cell Cardiol. 2009 Jun 30;47(4):493–503. doi: 10.1016/j.yjmcc.2009.06.016

Table 2.

Cardiac and plasma opioid peptide levels.

	Plasma β-endorphin (ng βE/mg protein)	Cardiac β-endorphin (ng βE/mg protein)	Plasma Dynorphin A (ng DA/mg protein)	Cardiac Dynorphin A (ng DA/mg protein)	Plasma Leu-enkephalin (ng LE/mg protein)	Cardiac Leu-enkephalin (ng LE/mg protein)
1mo F1B	0.080±0.01	0.296±0.16	0.048±0.1	0.198±0.11	4.031±1.34	1.879±0.55
1mo Bio14.6	0.109±0.4	0.264±0.16	0.086±0.03	0.139±0.06	3.396±0.98	2.069±1.13
9mo F1B	0.176±0.06	0.398±0.15	0.106±0.03	0.106±0.03	9.243±2.57	2.934±0.49
9mo Bio14.6	0.135±0.04	0.266±0.11	0.144±0.04	0.144±0.04	9.643±3.85	3.637±0.65

Data are mean±SEM.

n=9–15.

Bio14.6 hamsters at risk for (1 month) and in heart failure (9 months) as well as age-matched controls (F1B).